3. Treatment After a Clinical Trial
Depending on the different types of clinical trial, it’s expected that treatment ends with the end of the clinical trial. In some cases, patients continue to receive treatment after the end of the clinical trial, which is known as an “open label extension” of the study. In addition, patients may continue to be followed after receiving treatment in the clinical trial – a period called follow-up.
In the case of study participants of the control groups who were given placebos, they may also receive treatment after the clinical trial. It is important that patients clarify all these conditions and questions with the team responsible for the clinical trial and discuss with them all the options about gaining access to treatment after the end of the clinical trial. Participants should also review any documentation describing the trial, such as the Informed Consent Document.
Find out more about prostate cancer clinical trials here.
Learn more about prostate cancer through this link.
Prostate Cancer News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.